FRIERI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 2.676
EU - Europa 1.713
AS - Asia 720
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 5.128
Nazione #
US - Stati Uniti d'America 2.667
IE - Irlanda 581
CN - Cina 417
SE - Svezia 308
TR - Turchia 266
DE - Germania 181
UA - Ucraina 161
GB - Regno Unito 151
IT - Italia 149
FI - Finlandia 73
FR - Francia 67
BE - Belgio 18
VN - Vietnam 12
IN - India 11
CA - Canada 7
EU - Europa 6
NL - Olanda 6
RU - Federazione Russa 6
AU - Australia 5
JP - Giappone 5
BR - Brasile 3
EC - Ecuador 3
EE - Estonia 3
SG - Singapore 3
IL - Israele 2
LU - Lussemburgo 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
BM - Bermuda 1
BT - Bhutan 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
IQ - Iraq 1
IR - Iran 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
Totale 5.128
Città #
Jacksonville 646
Chandler 613
Dublin 581
Izmir 135
Nanjing 135
Ann Arbor 110
San Mateo 107
Boardman 103
New York 91
Lawrence 84
Princeton 84
Wilmington 73
Ashburn 55
Beijing 55
Woodbridge 42
Milan 41
L'aquila 33
Nanchang 33
Dearborn 30
Verona 25
Des Moines 22
Shenyang 22
Bremen 20
Kunming 19
Tianjin 19
Brussels 18
Hebei 18
Seattle 18
Jiaxing 17
Jinan 16
Norwalk 14
Dong Ket 12
Mountain View 12
Shanghai 12
Ningbo 11
Changsha 10
Hangzhou 9
L’Aquila 9
Auburn Hills 8
Los Angeles 8
Hefei 7
Zhengzhou 7
Falls Church 6
Guangzhou 6
Tappahannock 6
Helsinki 5
London 5
Taizhou 5
Amsterdam 4
Changchun 4
Lanzhou 4
Philadelphia 4
Pune 4
Chicago 3
Edinburgh 3
Fairfield 3
Fremont 3
Napoli 3
Phoenix 3
Quito 3
Redmond 3
Rome 3
Stockholm 3
Sydney 3
Tallinn 3
Borgaro Torinese 2
Brindisi 2
Chongqing 2
Gonzales 2
New Delhi 2
Ottawa 2
Prata 2
San Francisco 2
Seguin 2
São Paulo 2
Tokyo 2
Walnut 2
Auckland 1
Bend 1
Bergamo 1
Boulder 1
Budapest 1
Charlotte 1
Coventry 1
Douglas 1
Dubai 1
Eastwood 1
Gilbert 1
Haikou 1
Hamilton 1
Harbin 1
Houston 1
Irkutsk 1
Islington 1
Langley 1
Lethbridge 1
Luxembourg 1
Melbourne 1
Mentana 1
Montreal 1
Totale 3.520
Nome #
Association between vasomotor rhinitis and irritable bowel syndrome. 114
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 110
Association between colonic diverticula and colorectal polyps and cancer 107
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 98
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 97
Association between colorectal polyps and colonic diverticulosis 95
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 95
Histological healing in ulcerative colitis with mesalazine and its prognostic role 91
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 79
IgG4-Related Disease Mimicking Crohn’s Disease: A Case Report and Review of Literature 79
Ulcerative Colitis: rectal dilations in a patient with refractory diarrhoea. Report of a case 77
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 72
Effects of bombesin and bombesin-like peptides on gastrointestinal myoelectric activity 72
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 72
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 71
Advances in the pathogenesis of inflammatory bowel diseases: Capri 2010 71
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 71
Colonic involvement in celiac disease and possible implications of the sigmoid mucosa organ culture in its diagnosis. 71
Early acid perception in NERD 69
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 69
Short-chain fatty acids topical treatment in distal ulcerative colitis 68
Colonoscopic control of uretero-enteric anastomoses in internal urinary diversion. 66
Colonic electromyography in chronic constipation. 66
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 66
Dextran sulfate sodium (DSS) colitis in rats. Clinical, structural, and ultrastructual aspects 66
Mucosal healing: Mayo 0 vs 1 after 3 years. 66
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine 65
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 65
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 65
n-Butyrate Rectal Transport in Cirrhotic Patients 65
Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis Randomized, Double-Blind, Placebo-Controlled Pilot Study 64
Acute colitis following colonoscopy 64
Assesment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhancement MRI 63
Prognostic factors for post-operative recurrence of Crohn's disease 63
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-β1 downregulation 63
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 62
Carbonic andhydrase I reduction in colonic mucosa of patients with active ulcerative colitis 62
Management of colonic diverticular disease. 62
Lactose malabsorption and irritable bowel syndrome. Effect of a long-term lactose-free diet. 61
Multiple organ dysfunction in ulcerative colitis 61
Incidence of inflammatory Bowel disease in Italy: A nationwide population-based study 61
Abnormal Patterns of Colorectal Mucin Secretion after Urinary Diversion of Different Types: Histochemical and Lectin Binding Studies 61
Gastrointestinal: Eosinophilic ascites. 61
An unusual treatment for a colonic polyp. 60
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 60
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of postoperative recurrence of Crohn's disease 60
Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic biopsy samples in humans by high-performance liquid chromatography with electrochemical detection 60
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 59
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 59
GI distension in severe ulcerative colitis 58
Abnormal Patterns of Colonic Mucin Secretion after Ureterosigmoidostomy 58
Abnormalities of colonic mucin secretion and metabolic changes after internal urinary diversion for bladder extrophy. A prospective study. 57
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 56
Consequence of colonic involvement on electrolyte and acid-base homeostasis in crohn's disease 56
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 56
Current opinions on treatment of inflammatory bowel disease 55
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 55
Treatment of inflammatory bowel diseases: To heal the wound or to heal the sick? 55
Report of the 3rd National Congress of the Italian Federation of Coloproctology. 54
Il 5-ASA (Asacol) previene le recidive post-operatorie del morbo di Crohn. Risultati dello studio GISC a tre anni di follow-up. 54
Italian consensus guidelines for chronic pancreatitis. 53
Colonoscopy practice in Italy: a prospective survey on behalf of the Italian Association of Hospital Gastroenterologists 52
Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis 50
Historical evolution of the management of severe ulcerative colitis 50
Risk factors in toxic megacolon 49
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 49
Mucosal 5-ASA concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis 48
Mesalazine vanishing time from rectal mucosa following its topical administration. 48
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 45
Duodenal lymphocytosis in functional dyspepsia 45
Celiac disease, gluten-free diet, and metabolic and liver disorders 45
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 45
Is mesalazine treatment effective in the prevention of diverticulitis? A review 44
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 44
Meccanismi e approccio alla fisiopatologia della diarrea. 43
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 43
Faecal excretion of bicarbonate in ulcerative colitis 42
Genetic analysis in italian families with inflammatory bowel disease supports linkage to the IBD1 locus-a GISC study 42
The dyspeptic macrophage 30 years later. An update in the pathogenesis of Crohn's disease 41
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 41
The long journey of salicylates in ulcerative colitis: The past and the future. 40
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 40
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 38
Thecnical performance of colonoscopy: thekey role of sedation/analgesia and other quality indicators 36
The role on endoscopy in alcohol-related diseases 36
Prophylactic Treatment with Vedolizumab in the Prevention of Postoperative Recurrence (POR) in High-Risk Crohn's Patients 2
Totale 5.229
Categoria #
all - tutte 17.220
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.220


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019236 0 0 0 0 0 0 0 0 0 12 33 191
2019/2020730 140 6 77 8 4 122 124 20 112 26 6 85
2020/2021769 17 94 3 106 86 30 102 8 91 37 150 45
2021/2022569 38 49 132 45 23 4 11 31 26 28 36 146
2022/20231.716 113 95 29 197 151 191 0 113 746 8 47 26
2023/2024343 55 23 17 61 27 112 21 18 0 9 0 0
Totale 5.229